Vipul Organics (530627)

Score breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 2/2 · Dividend: 0/1

Key Financials

AI Analysis

AI-generated, general educational analysis — not personal investment advice.

This business reminds me that a wonderful business can be a terrible purchase at too high a price. Vipul Organics, a small specialty chemicals player, earns its keep but without the moat-like returns I demand. Book value is ₹36.62, yet the market asks ₹183.80 — over 5 times book — for a company earning just 9.44% on equity. That translates to a paltry earnings yield of roughly 1.5% at a P/E of 68.56. Graham would shake his head. The profit growth of 27.59% is eye-catching, especially against sales growth of 11.42%, suggesting margin expansion. But with a PEG of 3.51, the market has already priced in years of flawless execution. The Piotroski F-Score of 7/9 is a comfort; the company isn't deteriorating financially. Yet I cannot fully assess leverage because debt/equity is not given, and as a value investor I never rely on incomplete information. The latest quarter shows ₹46 Cr in sales and just ₹2 Cr in net profit — a thin 4.3% margin. If the company can scale that margin while keeping growth alive, the premium might someday be justified. But my discipline is to buy with a margin of safety, and at ₹183.80 there is none. A 0.39% dividend yield offers no support. This is an interesting fast grower, but for now it goes on my watchlist, not into my portfolio.

The full AI analysis, bull and bear case and key monitorables are in FairStock Pro.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer